tradingkey.logo
tradingkey.logo
Search

Immunitybio Inc

IBRX
Add to Watchlist
8.925USD
+0.475+5.62%
Market hours 09/22, 11:54ET
9.40BMarket Cap
LossP/E TTM

IBRX Financials

See Immunitybio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
9.40B
Dividend TTM
0.00
P/E TTM
-10.55
EPS TTM
-0.85
Revenue
113.29M
Net Profit
-413.56M
ROE
0.00%
ROA
-179.84%

Immunitybio Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-0.22/-0.09
Revenue / Forecast
51.24M/49.70M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-110.55%-0.22
-305.51%-0.62
22.46%-0.06
42.32%-0.07
46.81%-0.10
23.76%-0.15
76.86%-0.08
35.77%-0.12
37.85%-0.20
26.61%-0.20
-30.02%-0.35
---0.19
---0.32
---0.27
---0.27
----
----
----
----
----
Revenue
93.91%51.24M
167.64%44.21M
406.95%38.28M
425.07%32.06M
2423.88%26.43M
41192.50%16.52M
5333.09%7.55M
7346.34%6.11M
2453.66%1.05M
-88.89%40.00K
90.41%139.00K
-30.51%82.00K
17.14%41.00K
2471.43%360.00K
-81.28%73.00K
78.79%118.00K
-89.68%35.00K
-89.93%14.00K
1757.14%390.00K
-56.29%66.00K
Net Profit
-148.91%-230.38M
-388.08%-632.78M
-4.70%-61.94M
21.55%-67.25M
31.22%-92.56M
3.33%-129.65M
74.65%-59.16M
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
-115.67%-233.39M
13.84%-95.58M
-45.77%-137.88M
-13.15%-116.34M
-18.58%-108.22M
-26.60%-110.94M
-7.14%-94.59M
-29.16%-102.83M
-184.01%-91.26M
-33.57%-87.63M
Net Margin
-28.35%-449.63%
-82.34%-1431.47%
79.35%-161.83%
85.06%-209.83%
97.27%-350.33%
99.77%-785.05%
99.53%-783.62%
98.80%-1404.39%
96.19%-12854.25%
-935.46%-335325.00%
-13.16%-167923.74%
---116636.59%
---337104.88%
---32384.17%
---148391.78%
----
----
----
----
----
Gross Margin
-0.07%99.42%
-0.19%99.46%
-1.00%99.00%
-0.55%99.45%
-0.51%99.49%
-0.35%99.65%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
-4.79%189.25%
-34.91%167.57%
-17.99%160.08%
-40.93%157.97%
-7.65%198.76%
21.20%257.44%
17.45%195.21%
71.08%267.42%
-18.46%215.22%
1.66%212.41%
-10.73%166.21%
--156.31%
--263.96%
--208.95%
--186.19%
----
----
----
----
----
Revenue
93.91%51.24M
167.64%44.21M
406.95%38.28M
425.07%32.06M
2423.88%26.43M
41192.50%16.52M
5333.09%7.55M
7346.34%6.11M
2453.66%1.05M
-88.89%40.00K
90.41%139.00K
-30.51%82.00K
17.14%41.00K
2471.43%360.00K
-81.28%73.00K
78.79%118.00K
-89.68%35.00K
-89.93%14.00K
1757.14%390.00K
-56.29%66.00K
Operating profit
13.45%-61.70M
-8.32%-69.79M
6.80%-64.68M
30.68%-55.63M
28.24%-71.28M
32.32%-64.43M
17.87%-69.40M
-0.15%-80.25M
-16.66%-99.33M
14.68%-95.20M
-0.34%-84.50M
11.75%-80.14M
-6.94%-85.14M
-16.26%-111.58M
-6.24%-84.22M
-15.18%-90.80M
7.31%-79.62M
-11.25%-95.97M
-186.33%-79.27M
-42.77%-78.84M
Net Profit
-148.91%-230.38M
-388.08%-632.78M
-4.70%-61.94M
21.55%-67.25M
31.22%-92.56M
3.33%-129.65M
74.65%-59.16M
10.31%-85.73M
2.40%-134.56M
-15.27%-134.11M
-115.67%-233.39M
13.84%-95.58M
-45.77%-137.88M
-13.15%-116.34M
-18.58%-108.22M
-26.60%-110.94M
-7.14%-94.59M
-29.16%-102.83M
-184.01%-91.26M
-33.57%-87.63M
Current assets
110.91%438.98M
314.93%452.95M
70.58%314.88M
101.96%329.50M
-14.29%208.13M
-44.23%109.16M
-37.23%184.59M
-24.15%163.15M
263.38%242.83M
72.46%195.72M
109.20%294.08M
50.31%215.08M
-41.89%66.83M
-46.55%113.49M
-57.95%140.58M
51.50%143.09M
1.11%114.99M
113.25%212.34M
199.29%334.35M
-3.64%94.45M
Total current liabilities
51.50%76.73M
38.10%67.95M
12.39%61.75M
-6.28%57.13M
-18.46%50.64M
-8.47%49.20M
-5.73%54.94M
-32.51%60.96M
-89.88%62.11M
-90.48%53.76M
-88.36%58.28M
27.50%90.32M
63.14%613.48M
48.27%564.95M
35.74%500.86M
8.30%70.84M
405.25%376.05M
377.08%381.01M
441.57%369.00M
216.55%65.41M
Total assets
56.31%628.50M
112.88%646.64M
31.07%501.90M
42.36%518.99M
-9.51%402.08M
-24.19%303.76M
-24.09%382.93M
-15.69%364.57M
52.57%444.32M
16.68%400.68M
39.21%504.45M
22.52%432.42M
-8.34%291.23M
-11.86%343.40M
-22.72%362.36M
64.60%352.94M
29.00%317.72M
86.02%389.59M
111.81%468.91M
18.77%214.42M
Total liabilities
72.27%1.67B
69.50%1.52B
14.97%1.00B
-5.98%1.04B
-14.87%971.89M
-18.08%894.24M
-20.11%871.06M
31.51%1.11B
21.92%1.14B
24.74%1.09B
34.26%1.09B
7.81%843.06M
26.59%936.41M
20.35%875.12M
13.94%812.18M
93.40%782.02M
82.69%739.69M
84.20%727.14M
109.73%712.82M
1167.09%404.37M
Total equity
-83.53%-1.05B
-47.19%-869.13M
-2.34%-499.57M
29.66%-523.41M
18.29%-569.82M
14.54%-590.48M
16.69%-488.13M
-81.22%-744.16M
-8.09%-697.38M
-29.95%-690.98M
-30.26%-585.94M
4.30%-410.64M
-52.90%-645.18M
-57.52%-531.72M
-84.42%-449.82M
-125.90%-429.08M
-166.09%-421.97M
-82.13%-337.56M
-105.85%-243.91M
-227.80%-189.94M
Net operating income
16.62%-66.49M
12.28%-75.36M
17.34%-70.38M
30.23%-68.91M
20.53%-79.75M
19.70%-85.91M
26.14%-85.14M
-13.00%-98.76M
-25.79%-100.35M
-26.89%-106.98M
-27.05%-115.27M
-8.44%-87.40M
12.58%-79.77M
-12.52%-84.31M
-26.64%-90.73M
-10.84%-80.60M
-31.12%-91.25M
-23.91%-74.93M
-24.36%-71.64M
-96.58%-72.72M
Net investment
-565.77%-107.47M
-866.53%-31.65M
343.09%43.57M
-378.88%-181.36M
68.65%-16.14M
111.59%4.13M
337.26%9.83M
516.05%65.03M
-498.44%-51.49M
-319.87%-35.62M
111.90%2.25M
-1238.27%-15.63M
-107.37%-8.60M
87.76%-8.48M
86.29%-18.89M
-111.04%-1.17M
1012.33%116.67M
-317.66%-69.31M
-1926.40%-137.80M
118.69%10.58M
Net financing
-74.28%44.44M
22903.05%223.93M
-48.66%54.89M
1013.59%173.52M
16.06%172.81M
-109.60%-982.00K
-46.68%106.93M
-93.44%15.58M
242.98%148.89M
-86.70%10.22M
82.41%200.54M
91.56%237.50M
289513.33%43.41M
25901.34%76.89M
-66.27%109.94M
190.66%123.99M
-100.02%-15.00K
-100.77%-298.00K
135150.21%325.95M
-32.52%42.66M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its total revenue reached 113.29M, with a year-on-year change of 14.74M.

What are the current assets of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its current assets were 314.88M, with a year-on-year change of 70.58.

What are the total assets of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its total assets of Immunitybio Inc were 501.90M, with a year-on-year change of 31.07.

What are the total liabilities of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its total liabilities of Immunitybio Inc were 1.00B, with a year-on-year change of 14.97.

What is the total equity of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its total equity of Immunitybio Inc was -499.57M, with a year-on-year change of -2.34.

What is the net operating income of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its net operating income of Immunitybio Inc was -256.03M, with a year-on-year change of 25.61.

What is the net investment of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its net investment of Immunitybio Inc was -149.80M, with a year-on-year change of -1123.26.

What is the net financing of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its net financing of Immunitybio Inc was 400.24M, with a year-on-year change of 42.12.

What is the Earnings Per Share (EPS) of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.38, with a year-on-year change of 35.59.

What is the net income of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its net income was -351.40M, with a year-on-year change of 15.03.

What is the net margin of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its net profit margin was -310.25, with a year-on-year change of 88.94.

What is the gross margin of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its gross margin was 99.34, with a year-on-year change of -0.66.

What is the debt-to-asset ratio of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its debt-to-asset ratio was 160.08, with a year-on-year change of -17.99.

What is the Return on Assets (ROA) of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its Return on Assets (ROA) was -79.44, with a year-on-year change of 14.79.

What is the operating profit of Immunitybio Inc?

According to Immunitybio Inc's FY2025 earnings report, its operating profit was -256.03M, with a year-on-year change of 25.61.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.